4.6 Article

Ras-induced Epigenetic Inactivation of the RRAD ( Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 289, 期 20, 页码 14225-14238

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M113.527671

关键词

DNA Methylation; Metabolism; Ovarian Cancer; Ras; Tumor Suppressor Gene; Oncogenic Transformation; RRAD

资金

  1. Natural Science Foundation of China (NSFC)-Canadian Institutes of Health Research Collaborative Research Project Grant [81161120541]
  2. National High-tech RD Program Grant [2012AA02A202]
  3. NSFC [31171236/C060503, 31200976]
  4. Zhejiang Provincial Natural Science Foundation of China [Z2110521]
  5. Innovation Center China of AstraZeneca

向作者/读者索取更多资源

Background: Increased glucose uptake is essential for carcinogenesis. Results: Ras(V12)-induced epigenetic inactivation of RRAD promotes glucose uptake and tumor formation. Conclusion: RRAD might act as a functional tumor suppressor by inhibiting glucose uptake. Significance: Down-regulation of RRAD in tumor tissues might be associated with the Warburg effect. RRAD (Ras-related associated with diabetes) is a small Ras-related GTPase that is frequently inactivated by DNA methylation of the CpG island in its promoter region in cancer tissues. However, the role of the methylation-induced RRAD inactivation in tumorigenesis remains unclear. In this study, the Ras-regulated transcriptome and epigenome were profiled by comparing T29H (a Ras(V12)-transformed human ovarian epithelial cell line) with T29 (an immortalized but non-transformed cell line) through reduced representation bisulfite sequencing and digital gene expression. We found that Ras(V12)-mediated oncogenic transformation was accompanied by RRAD promoter hypermethylation and a concomitant loss of RRAD expression. In addition, we found that the RRAD promoter was hypermethylated, and its transcription was reduced in ovarian cancer versus normal ovarian tissues. Treatment with the DNA methyltransferase inhibitor 5-aza-2-deoxycytidine resulted in demethylation in the RRAD promoter and restored RRAD expression in T29H cells. Additionally, treatment with farnesyltransferase inhibitor FTI277 resulted in restored RRAD expression and inhibited DNA methytransferase expression and activity in T29H cells. By employing knockdown and overexpression techniques in T29 and T29H, respectively, we found that RRAD inhibited glucose uptake and lactate production by repressing the expression of glucose transporters. Finally, RRAD overexpression in T29H cells inhibited tumor formation in nude mice, suggesting that RRAD is a tumor suppressor gene. Our results indicate that Ras(V12)-mediated oncogenic transformation induces RRAD epigenetic inactivation, which in turn promotes glucose uptake and may contribute to ovarian cancer tumorigenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据